Related Experiment Video

Updated: Oct 2, 2025

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles
10:26

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

8.6K

Novel strategies for targeting the thioredoxin system for cancer therapy

Qianhe Xu1, Junmin Zhang1

  • 1School of Pharmacy, State Key Laboratory of Applied Organic Chemistry, and College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, Gansu, China.

Expert Opinion on Drug Discovery
|February 23, 2022
PubMed
Abstract

Insights

Targeting the thioredoxin system offers a promising strategy for developing novel anticancer therapeutics by uncovering new protein functions and regulatory pathways. Synergistic approaches show potential in overcoming chemotherapy resistance and enhancing immunotherapy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • The thioredoxin system is crucial for maintaining cellular redox balance and regulating signaling pathways.
  • Its role in cellular processes makes it a significant target for cancer treatment strategies.

Purpose of the Study:

  • To review recent advancements (past five years) in targeting the thioredoxin system for anticancer therapeutics.
  • To highlight novel protein functions, regulatory pathways, and therapeutic reagent design.
  • To provide expert perspectives on future research directions.

Main Methods:

  • Literature review focusing on the thioredoxin system in cancer therapy.
  • Analysis of recent discoveries in protein function and pathway regulation.
  • Evaluation of therapeutic reagent development and clinical research progress.

Main Results:

  • Recent research has identified novel functions and downstream pathways within the thioredoxin system.
  • New therapeutic reagents targeting this system have been designed.
  • Progress in clinical translation of thioredoxin-targeted therapies has been observed.

Conclusions:

  • Targeting the thioredoxin system is a viable strategy for developing new anticancer drugs.
  • Synergistic targeting shows promise for overcoming chemotherapy resistance and improving immunotherapy efficacy.
  • Novel strategies are needed to accelerate clinical development due to limitations in current inhibitors and research progress.
Keywords:
Thioredoxincancer therapyredox regulationstrategiesthioredoxin reductase

More Related Videos

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by GalliumIII and H3 5,10,15-trispentafluorophenylcorroles09:00

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by GalliumIII and H3 5,10,15-trispentafluorophenylcorroles

Published on: March 18, 2015

11.7K
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

698

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.2K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
708